347 related articles for article (PubMed ID: 27708003)
1. An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
Raj L; Adhyaru B
Postgrad Med J; 2016 Dec; 92(1094):726-734. PubMed ID: 27708003
[TBL] [Abstract][Full Text] [Related]
2. Heart Failure Guidelines on Pharmacotherapy.
Papadimitriou L; Hamo CE; Butler J
Handb Exp Pharmacol; 2017; 243():109-129. PubMed ID: 28451824
[TBL] [Abstract][Full Text] [Related]
3. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
Naegele M; Flammer AJ; Enseleit F; Ruschitzka F
Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014
[TBL] [Abstract][Full Text] [Related]
4. Heart Failure Update: Outpatient Management.
Wojnowich K; Korabathina R
FP Essent; 2016 Mar; 442():18-25. PubMed ID: 26974001
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
Lim WY; Woldman S
Br J Hosp Med (Lond); 2013 Feb; 74(2):C18-22. PubMed ID: 23411909
[No Abstract] [Full Text] [Related]
6. [Pharmacological therapy of heart failure with reduced ejection fraction].
Wieser M; Rhyner D; Martinelli M; Suter T; Schnegg B; Bösch C; Wigger O; Dobner S; Hunziker L
Ther Umsch; 2018 Sep; 75(3):180-186. PubMed ID: 30145973
[TBL] [Abstract][Full Text] [Related]
7. Current medical therapy for advanced heart failure.
Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
Heart Lung; 2000; 29(1):16-32. PubMed ID: 10636954
[No Abstract] [Full Text] [Related]
8. The ABCs of managing systolic heart failure: Past, present, and future.
Okwuosa IS; Princewill O; Nwabueze C; Mathews L; Hsu S; Gilotra NA; Lewsey S; Blumenthal RS; Russell SD
Cleve Clin J Med; 2016 Oct; 83(10):753-765. PubMed ID: 27726827
[TBL] [Abstract][Full Text] [Related]
9. A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction.
Nguyen E; Weeda ER; White CM
J Clin Pharmacol; 2016 Aug; 56(8):936-47. PubMed ID: 26626162
[TBL] [Abstract][Full Text] [Related]
10. Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
Sionis A; ; Sionis Green A; Manito Lorite N; Bueno H; Coca Payeras A; Díaz Molina B; González Juanatey JR; Ruilope Urioste LM; Zamorano Gómez JL; ; Almenar Bonet L; Ariza Solé A; Bover Freire R; Lambert Rodríguez JL; López de Sá E; López Fernández S; Martín Asenjo R; Mirabet Pérez S; Pascual Figal D; Segovia Cubero J; Varela Román A; ; San Román Calvar JA; Alfonso Manterola F; Arribas Ynsaurriaga F; Evangelista Masip A; Ferreira González I; Jiménez Navarro M; Marin Ortuño F; Pérez de Isla L; Rodríguez Padial L; Sánchez Fernández PL; Sionis Green A; Vázquez García R
Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1119-1125. PubMed ID: 27894486
[No Abstract] [Full Text] [Related]
11. Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction.
Sandhu AT; Kohsaka S; Turakhia MP; Lewis EF; Heidenreich PA
JAMA Cardiol; 2022 Feb; 7(2):130-139. PubMed ID: 34757380
[TBL] [Abstract][Full Text] [Related]
12. Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF).
McMurray JJ; Packer M; Desai AS; Gong J; Lefkowitz M; Rizkala AR; Rouleau JL; Shi VC; Solomon SD; Swedberg K; Zile MR;
Eur J Heart Fail; 2014 Jul; 16(7):817-25. PubMed ID: 24828035
[TBL] [Abstract][Full Text] [Related]
13. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
[TBL] [Abstract][Full Text] [Related]
14. Heart Failure.
Wu A
Ann Intern Med; 2018 Jun; 168(11):ITC81-ITC96. PubMed ID: 29868816
[TBL] [Abstract][Full Text] [Related]
15. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
[TBL] [Abstract][Full Text] [Related]
16. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
Komajda M; Anker SD; Cowie MR; Filippatos GS; Mengelle B; Ponikowski P; Tavazzi L;
Eur J Heart Fail; 2016 May; 18(5):514-22. PubMed ID: 27095461
[TBL] [Abstract][Full Text] [Related]
17. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
[TBL] [Abstract][Full Text] [Related]
18. Heart failure in African Americans: disparities can be overcome.
Sharma A; Colvin-Adams M; Yancy CW
Cleve Clin J Med; 2014 May; 81(5):301-11. PubMed ID: 24789589
[TBL] [Abstract][Full Text] [Related]
19. Medical therapy following hospitalization for heart failure with reduced ejection fraction and association with discharge to long-term care: a cross-sectional analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population.
Levitan EB; Van Dyke MK; Chen L; Durant RW; Brown TM; Rhodes JD; Olubowale O; Adegbala OM; Kilgore ML; Blackburn J; Albright KC; Safford MM
BMC Cardiovasc Disord; 2017 Sep; 17(1):249. PubMed ID: 28915854
[TBL] [Abstract][Full Text] [Related]
20. Neprilysin Inhibitors in Cardiovascular Disease.
Kang G; Banerjee D
Curr Cardiol Rep; 2017 Feb; 19(2):16. PubMed ID: 28185171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
